Hill International to Provide Project Management and Supervision Consultancy Services for the International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt
Hill International has been selected by Egypt's Ministry of Defense to provide project management and consultancy for the new International Stem Cell and Regenerative Medicine Research and Therapeutic Center. This initiative aims to enhance Egypt's healthcare infrastructure and includes a research facility, animal welfare facility, and bioreactor facility. The Center will focus on stem cell research and regenerative medicine, utilizing advanced medical technology. Hill's involvement highlights its commitment to impactful projects in the region, with a focus on advancing healthcare and contributing to global stem cell research.
- Selected by Egypt's Ministry of Defense for a major healthcare project.
- Focus on advancing stem cell research and regenerative medicine.
- Project includes state-of-the-art facilities to enhance healthcare in Egypt.
- None.
PHILADELPHIA and CAIRO, Egypt, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Hill International (NYSE:HIL), delivering the infrastructure of change, announced today it was selected by Egypt’s Ministry of Defense to provide project management and supervision consultancy services for the International Stem Cell and Regenerative Medicine Research and Therapeutic Center project. The project represents the latest effort of the Egyptian Armed forces to enrich the country’s healthcare sector.
The project consists of three components: a research facility, an animal welfare facility, and a bioreactor facility. In cooperation with academic, industrial, governmental, and non-governmental institutions, Center staff will use these new facilities to conduct basic and preclinical studies as well as clinical trials with stem cells. Ultimately, the project will leverage the therapeutic potential of stem cells to develop cellular therapies, tissues, and organs to advance regenerative medicine and promote health and welfare in Egypt and around the world.
Hill Senior Vice President and Managing Director for Africa Waleed Abdel-Fattah says: “The International Stem Cell and Regenerative Medicine Research and Therapeutic Center will require the latest in building systems and medical technology. Our team has helped to manage cutting-edge healthcare research and hospital facilities across the region, and we will use our expertise to make certain the new Center is realized as planned.”
“This project represents a great step for the country,” adds Hill Chief Executive Officer Raouf Ghali. “It will benefit Egyptians by advancing healthcare for all, continue the country’s growth trajectory, and position Egypt to make contributions of global significance to stem cell research. Hill is proud to add such an impactful project to our portfolio in the country.”
About Hill International
Hill International, with more than 3,200 professionals in over 100 offices worldwide, provides program management, project management, construction management, project management oversight, construction claims, dispute resolution, advisory, facilities management, and other consulting services to clients in a variety of market sectors. Engineering News-Record magazine recently ranked Hill as one of the largest construction management firms in the United States. For more information on Hill, please visit our website at www.hillintl.com.
Forward Looking Statements
Certain statements contained herein may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is our intent that any such statements be protected by the safe harbor created thereby. Except for historical information, the matters set forth herein including, but not limited to, any statements of belief or intent, any statements concerning our plans, strategies, and objectives for future operations are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although we believe that the expectations, estimates, and assumptions reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Important factors that could cause our actual results to differ materially from estimates or projections contained in our forward-looking statements are set forth in the Risk Factors section and elsewhere in the reports we have filed with the Securities and Exchange Commission, including that unfavorable global economic conditions may adversely impact our business, our backlog may not be fully realized as revenue, and our expenses may be higher than anticipated. We do not intend, and undertake no obligation, to update any forward-looking statement.
Hill International, Inc.
Elizabeth J. Zipf, LEED AP BD+C
Senior Vice President
(215) 309-7707
elizabethzipf@hillintl.com
The Equity Group, Inc.
Devin Sullivan
Senior Vice President
(212) 836-9608
dsullivan@equityny.com
FAQ
What role did Hill International play in the project announced on August 30, 2022?
What are the components of the International Stem Cell and Regenerative Medicine Research Center?
How will the new center benefit healthcare in Egypt?